Report #2830518

Overview

Sex

Unknown

Age

Age unknown

State

IL

Recovered

Unknown

Vaccinated

—

Onset

—

Days to onset

—

Hospital days

—

Symptoms (1)

Symptom narrative

Llss than recommended interval/patient received the second dose a month later; This non-serious case was reported by a physician via sales rep and described the occurrence of drug dose administration interval too short in a patient who received Herpes zoster (Shingrix) for prophylaxis. Concomitant products included Varicella zoster vaccine rgE (CHO) (Shingrix). On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced drug dose administration interval too short (Verbatim: Llss than recommended interval/patient received the second dose a month later). The outcome of the drug dose administration interval too short was not applicable. Additional Information: GSK receipt date: 04-MAR-2025 The physician asked if the patient received the second dose of Shingrix a month later which led to, drug dose administration interval too short. The reporter reported that the patient was not immunocompromised. The reporter had a questioned did they need to get a third dose. The Vaccine Administration Facility is the same as Primary Reporter.

Other medications

SHINGRIX